Patents for A61P 27 - Drugs for disorders of the senses (53,017)
02/2011
02/09/2011EP2281563A1 2,4-Pyrimidinediamine compounds and their uses
02/09/2011EP2281560A1 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy
02/09/2011EP2281554A1 Eye drop composition comprising ketotifen
02/09/2011EP2281002A2 Anti-alk1 antibodies and uses thereof
02/09/2011EP2280970A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors
02/09/2011EP2280722A2 Method of treating degenerative diseases
02/09/2011EP2280689A1 Stable ophthalmic formulations
02/09/2011EP1370276B1 Intercellular communication facilitating compounds and their medical use
02/09/2011CN101970670A Methods for inhibiting angiogenesis using egfl8 antagonists
02/09/2011CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors
02/09/2011CN101969940A A medicament comprising a parasympathetic agonist and a sympathetic antagonist or a sympathetic agonist
02/09/2011CN101969938A Methods for the treatment and prevention of age-related retinal dysfunction
02/09/2011CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis
02/09/2011CN101966286A Traditional Chinese medicine for treating diabetic eye diseases
02/09/2011CN101966275A Chinese medicinal preparation for treating deafness caused by deficiency-heat
02/09/2011CN101966258A Traditional Chinese medicine for treating diabetic retinopathy
02/09/2011CN101966246A Compound tincture for treating external acoustic meatus fungal infection
02/09/2011CN101966233A Preparation method of tuber fleeceflower root formulation granules
02/09/2011CN101966144A Preparation and application of olopatadine in-situ gel
02/09/2011CN101966143A Preparation and application of gatifloxacin temperature and pH sensitive ophthalmic gel
02/09/2011CN101084880B Biological solid dispersion of vitamin E esters derivatives and preparation method thereof
02/09/2011CN101068810B Carbostyril compound
02/08/2011US7884100 selective antagonists of A2B adenosine receptors for treatment of asthma, diabetic retinopathy
02/08/2011US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
02/08/2011US7883713 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans
02/08/2011CA2494300C Growth hormone releasing peptides
02/08/2011CA2484450C Ligands that are inhibitors of the rar receptors
02/08/2011CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
02/08/2011CA2439117C Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide
02/03/2011WO2011014661A2 Liver x receptor agonists
02/03/2011WO2011014587A2 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
02/03/2011WO2011014332A1 Selective alpha 2b/2c agonists
02/03/2011WO2011013794A1 Water-based composition for eye drop
02/03/2011WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same
02/03/2011WO2011013699A1 Carrier peptide fragment and use thereof
02/03/2011WO2011013651A1 Bicyclic compound and use thereof for medical purposes
02/03/2011WO2011012585A1 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
02/03/2011WO2011012557A1 Ophthalmic solution for protecting internal structures of the eyeball against uv-a rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
02/03/2011WO2009132050A9 Auris formulations for treating otic diseases and conditions
02/03/2011US20110028807 Contact lens for collecting tears and detecting at least one analyte
02/03/2011US20110028561 Protection of neural retina by reduction of rod metabolism
02/03/2011US20110028534 RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS
02/03/2011US20110028532 Methods of treating eye diseases in diabetic patients
02/03/2011US20110028531 Novel sirna compounds for inhibiting rtp801
02/03/2011US20110028523 Selective Alpha 2B/2C Agonists
02/03/2011US20110028516 Stabilized and preserved ketoifen ophthalmic compositions
02/03/2011US20110028509 Sulfonamides
02/03/2011US20110028503 Compositions and methods for inhibition of the jak pathway
02/03/2011US20110028482 Isoxazolines as inhibitors of fatty acid amide hydrolase
02/03/2011US20110028478 Isoxazolines as inhibitors of fatty acid amide hydrolase
02/03/2011US20110028477 Stable ophthalmic formulations
02/03/2011US20110028442 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor
02/03/2011US20110028434 Long-chain polyunsaturated fatty acids (lc-pufa) in maternal nutrition during pregnancy and lactation
02/03/2011US20110028431 Oral mucoadhesive dosage form
02/03/2011US20110028428 Hirsutella sinensis mycelia compositions and methods for treating sepsis and related inflammatory responses
02/03/2011US20110028398 Methods for treating and limiting fibrotic disorders and keloids
02/03/2011US20110028397 Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders
02/03/2011US20110027376 Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds
02/03/2011US20110027348 Composition and method inhibiting inflammation
02/03/2011US20110027333 Stem cell-derived retin retinal pigment epithelial cells
02/03/2011US20110027215 Protein-based polymer tissue adhesives for medical use
02/03/2011US20110027214 Polyquaternium- 1 synthesis methods
02/03/2011US20110027191 Optical imaging agent
02/03/2011US20110027185 Methods of Screening for Anti-Angiogenic Compounds
02/03/2011US20110027177 Inhibition of angiogenesis
02/03/2011CA2805511A1 Ophthalmic solution for protecting internal structures of the eyeball against uv-a rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
02/03/2011CA2769203A1 Liver x receptor agonists
02/03/2011CA2768981A1 Ligands that bind tgf-beta receptor rii
02/03/2011CA2768527A1 Compounds - 801
02/03/2011CA2768492A1 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
02/03/2011CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same
02/03/2011CA2767083A1 Bicyclic compound and use thereof for medical purposes
02/02/2011EP2280071A2 Haemophilus influenzae antigens and corresponding DNA fragments
02/02/2011EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors
02/02/2011EP2279169A2 Therapeutic compounds
02/02/2011EP2278999A2 Auris formulations for treating otic diseases and conditions
02/02/2011EP2278966A2 Treatment with opioid antagonists and mtor inhibitors
02/02/2011EP1861114B1 Compositions comprising modulators of g-protein-coupled receptor for treatment of macular degeneration
02/02/2011EP1343520B1 New therapeutic uses of smr1 peptides
02/02/2011CN1927195B Film agent comprising sodium gualenate using for eyes
02/02/2011CN101965196A Sugar chain-related gene and use thereof
02/02/2011CN101965188A Treatment for ocular-related disorders
02/02/2011CN101965183A Ophthalmic nsaids as adjuvants
02/02/2011CN101961497A Inhibition of Syk kinase expression
02/02/2011CN101961486A 一种滴眼液及其制备方法 One kind of eye drops and its preparation method
02/02/2011CN101961350A Preparation method of fishy smell-removed pearl powder
02/02/2011CN101961344A Drug composite and application thereof
02/02/2011CN101961332A Nimodipine ophthalmic preparation and preparation method thereof
02/02/2011CN101664508B Drug combination for treating centrality serous chorioretinitis
02/02/2011CN101653413B Tacrolimus ophthalmic emulsion and its preparation method
02/02/2011CN101596208B Medicine composition for treating burns, scalds, tympanitis and ulceratiue stomatitis
02/02/2011CN101317621B Mulberry leaf containing freezing beverage and preparation method thereof
02/01/2011US7879966 pH-sensitive polymer
02/01/2011US7879865 central nervous system disorders; brain cancer; oral administration
02/01/2011US7879832 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
02/01/2011US7879323 Antibodies to fibroblast growth factor-like polypeptides
02/01/2011CA2484935C Amide derivatives as inhibitors of the enzymatic activity of renin
02/01/2011CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers
02/01/2011CA2466140C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
02/01/2011CA2453442C Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases